This test uses Polymerase Chain Reaction (PCR) technology for the qualitative detection of Neisseria gonorrhoeae DNA in clinical samples. The method is distinguished by exceptional sensitivity and specificity (reaching >95%), allowing it to detect very small amounts of bacteria even in samples where traditional culture fails to isolate it, and also allows the use of non-invasive samples like first-void urine.